Condition

Membranous Nephropathy clinical trials and research

• 15Clinical trials
• 5NIH research projects
• 8Countries

Newest Membranous Nephropathy clinical trials

All recruiting trials (15)

• Rituximab plus Cyclosporine for Primary Membranous Nephropathy

  This study tests whether adding Cyclosporine to Rituximab helps people with primary membranous nephropathy achieve remission of heavy protein in the urine faster.

  Recruiting Phase 2/3 Peking University First Hospital · Beijing · NCT07861204

• HLX79 with rituximab (HLX01) for active glomerulonephritis

  This trial will test whether adding HLX79 at different doses to rituximab (HLX01) helps adults with active membranous nephropathy or lupus nephritis.

  Recruiting Phase 2 Shanghai Henlius Biotech · Beijing and 16 other locations · NCT07038382

• Using Raman Spectroscopy to Diagnose Kidney Diseases

  This study is testing a new way to diagnose kidney diseases by analyzing urine and blood samples from patients with specific kidney conditions to see if it can help identify the diseases more accurately.

  Recruiting Qianfoshan Hospital · Jinan, Shandong · NCT06760845

• Testing ManNAc for treating kidney disease FSGS

  This study is testing if a new oral treatment called ManNAc can help adults with kidney disease FSGS by reducing protein levels in their urine and checking how safe it is over 12 weeks.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06664814

• AI-guided personalized rituximab for membranous nephropathy

  This trial will test whether an AI-guided approach to dosing rituximab improves remission in adults with PLA2R1-positive nephrotic membranous nephropathy.

  Recruiting at 13 sites Phase 3 Centre Hospitalier Universitaire de Nice · Besançon and 13 other locations · NCT06341205

• Long-term outcomes in primary membranous nephropathy

  This project will follow adults with primary membranous nephropathy and nephrotic syndrome to see how their disease and real-world treatments affect long-term kidney outcomes.

  Recruiting Mario Negri Institute for Pharmacological Research · Bergamo, BG and 1 other locations · NCT06242327

• National Registry for Rare Kidney Diseases

  This study is collecting health information from people with rare kidney diseases to help improve treatments and create better care guidelines.

  Recruiting UK Kidney Association · Bristol, South West · NCT06065852

• Assessing urinary biomarkers in membranous glomerulonephritis

  This study is testing if urine samples can provide useful information about kidney health in people who have just been diagnosed with membranous glomerulonephritis.

  Recruiting Chinese University of Hong Kong · Shatin · NCT05688865

• Exploring experiences of patients and parents dealing with swelling from Nephrotic Syndrome

  This study talks to patients and parents about their experiences with swelling from Nephrotic Syndrome to help create better ways to measure how new treatments work.

  Recruiting University of Michigan · Ann Arbor, Michigan · NCT05505500

• NEPTUNE Match: Personalized matching of patients to kidney treatment options

  This project will try a system that matches people in the NEPTUNE cohort who have nephrotic syndromes or related kidney diseases with suitable clinical trials and shares those matches with patients and their doctors.

  Recruiting at 15 sites University of Michigan · Atlanta, Georgia and 15 other locations · NCT04571658

• National collection of membranous nephropathy cases in France

  This project tests a one-year national collection of membranous nephropathy cases in France to learn about incidence, antibodies, outcomes, and risk factors.

  Recruiting Centre Hospitalier Universitaire de Nice · Nice, Alpes Maritime · NCT04326218

• Investigating B Cells in Membranous Nephropathy

  This study looks at how certain immune cells called B-cells affect whether patients with membranous nephropathy respond to a specific treatment that targets these cells.

  Recruiting Mario Negri Institute for Pharmacological Research · Ranica, BG · NCT04095156

• Combining belimumab and rituximab for treating primary membranous nephropathy

  This study is testing if combining two medications, belimumab and rituximab, can help adults with primary membranous nephropathy feel better and achieve remission more effectively than using rituximab alone.

  Recruiting at 20 sites Phase 2 National Institute of Allergy and Infectious Diseases (NIAID) · Birmingham, Alabama and 19 other locations · NCT03949855

• A network for analyzing kidney biopsy data in glomerular diseases

  This study is trying to build a detailed database of kidney biopsy samples and health information from patients with glomerular diseases to help researchers better understand these conditions and improve treatments.

  Recruiting at 6 sites Seoul National University Hospital · Chuncheon and 5 other locations · NCT03929887

• Observational study on nephrotic syndrome and its causes

  This study is trying to learn more about nephrotic syndrome and its different types to improve how we treat it and help patients feel better.

  Recruiting at 33 sites University of Michigan · Los Angeles, California and 43 other locations · NCT01209000

NIH-funded research (5)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Real-world insights on membranous nephropathy treatments for adults and children

  This grant tests how different real-world treatments for membranous nephropathy perform over time using observational health data.

  NIH research Children's Hosp of Philadelphia · Philadelphia, United States · NIH-11365444

• Investigating how lipoic acid affects autoimmune kidney disease.

  This study is looking at how the dietary supplement lipoic acid might affect people with membranous nephropathy, a kidney disease, by seeing if it triggers immune responses that could lead to complications, so we can better spot and treat those at risk.

  NIH research Oregon Health & Science University · Portland, United States · NIH-11145020

• Investigating the role of HTRA1 in causing kidney disease

  This study is looking at how certain antibodies in people with primary membranous nephropathy (a kidney condition) affect the disease and aims to find better ways to diagnose and treat it, using new animal models to learn more about how the disease works.

  NIH research University of Utah · Salt Lake City, United States · NIH-11075806

• Identifying harmful T cells in patients with membranous nephropathy.

  This study is looking at how certain immune cells called T cells behave in people with membranous nephropathy, a kidney disease, to help find better ways to understand and treat the condition.

  NIH research Icahn School of Medicine at Mount Sinai · New York, United States · NIH-10908643

• Understanding how autoantibodies affect kidney function in membranous nephropathy

  This study is looking at how certain antibodies in the body affect kidney health in people with primary membranous nephropathy, with the hope of finding better ways to treat the disease and help patients feel better.

  NIH research Boston Medical Center · Boston, United States · NIH-10667599

Related topics

Quick answers

How many Membranous Nephropathy clinical trials are recruiting right now?

15, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 8 countries. The most sites are in United States (5 trials), China (3 trials), France (2 trials), Italy (2 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 2/3: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →